New gel aims to stop surgical bleeding in minutes
NCT ID NCT07284953
Summary
This study aimed to test a new gel called PuraBond, designed to quickly stop bleeding and help tissue heal after surgeons remove part of a kidney to treat cancer. The gel would have been tested in patients undergoing robotic surgery where standard methods to stop bleeding were not enough. The goal was to see if the gel was safe and effective, but the study was withdrawn before any patients were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Royal Wolverhampton NHS Trust
Wolverhampton, WV10 0QP, United Kingdom
Conditions
Explore the condition pages connected to this study.